Identification and Validation of a Novel Multi-Omics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma
Ling Ji , Xiaofeng Li, Qiu Wang, Jiantong Zheng, Xiuqing Liu; Abraham Jia.
- Name: Ling Ji
- Phone: +86-13714685518
- Country: China
- Received date: 28 February, 2022
- Accepted date: 23 June, 2022
- Published date: 30 June, 2022
Designation: Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, PR China
Citation: Ji L, Li X, Wang Q, Zheng J, Liu X, et al. (2022) Identification and Validation of a Novel Multi-Omics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma. J Biomed Res Rev Vol: 5, Issu: 1. (28-38).
Copyright: © 2022 Ji L et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Fulltext Under Construction
Journals
Conferences
Reprints
Guidelines
Subscribe
This work is licensed under a
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright @ Innovation Info, All Rights Reserved.